Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth. Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development.
Further Key Findings from the Study Suggest:
CSF management devices are expected to witness extensive competition owing to presence of several market players operating in this segment. Rise in number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.
CSF shunts captured the largest market share in terms of revenue generation in 2014.
These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.
CSF drainage is anticipated to witness lucrative growth over the forecast period.
This growth can be attributed to ongoing development for enhancing overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.
In 2014, North America accounted for the largest share with respect to revenue generation.
Factors contributive for the share include continuous increase in the number of Americans affected from Hydrocephalus coupled with ongoing research in neuroscience.
Asia Pacific is expected to propel with fastest CAGR owing to constantly improving healthcare system in the region.
Moreover, economic progress of Asia Pacific countries such as China has led to significant transformation of neurology and neurologic practices in the country. This is one of the key drivers to propel progress in this region in the coming years.
Some of the key players operating in the market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.
These players are engaged in development of novel platforms for CSF management.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
1.1 Information Procurement
1.2 Data Analysis
2 Executive Summary
3 CSF Management Industry Outlook
3.1 Market segmentation
3.2 Market size and growth prospects, 2012 - 2022
3.3 CSF Management market dynamics
3.3.1 Market driver analysis
188.8.131.52 Technological advances driving growth
184.108.40.206 Growing base of aging population more prone to chronic diseases such as Parkinson’s and Alzheimer’s disorders
220.127.116.11 Increasing demand for minimally invasive surgeries
18.104.22.168 Rising cases of stroke and hydrocephalus
3.3.2 Market restraint analysis
22.214.171.124 Rising intricacies of clinical trials
126.96.36.199 Hospital budget constraints & alternative treatment facilities
3.4 Key opportunities prioritized, 2014
3.5 Industry analysis - Porter’s
3.6 CSF management PESTEL Analysis
4 CSF Management Product Outlook
4.1 Global CSF Management Revenue Share, by Product, 2014 & 2022
4.1.1 CSF shunts
188.8.131.52 CSF shunts devices market, 2012 - 2022 (USD Million)
4.1.2 CSF Drainage
184.108.40.206 CSF drainage devices market, 2012 - 2022 (USD Million)
5 CSF Management Regional Outlook
5.1 CSF management revenue share, by region, 2014 & 2022
5.2 North America
5.2.1 North America CSF management market, 2012 - 2022 (USD Million)
5.3.1 Europe CSF management market, 2012 - 2022 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific CSF management market, 2012 - 2022 (USD Million)
5.5.1 RoW CSF management market, 2012 - 2022 (USD Million)
6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 B. Braun Melsungen AG
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Johnson & Johnson Services, Inc
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Integra LifeSciences Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Spiegelberg GmbH & Co. KG
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 Medtronic, Inc.
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 BECKERSMITH MEDICAL, Inc
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 Phoenix Biomedical Corp.
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 Möller Medical GmbH
6.11.1 Company overview
6.11.2 Financial performance
6.11.3 Product benchmarking
6.11.4 Strategic initiatives
6.12 Elekta AB
6.12.1 Company overview
6.12.2 Financial performance
6.12.3 Product benchmarking
6.12.4 Strategic initiatives
List of Tables
Table 1 CSF Management - Industry Snapshot & Key Buying Criteria, 2012 - 2022
Table 2 Global CSF management market, by product, 2012 - 2022 (USD Million)
Table 3 CSF Management market, by region, 2012 - 2022 (USD Million)
Table 4 CSF Management - Key market driver analysis
Table 5 CSF management - Key market restraint analysis
Table 6 North America CSF management market, by product, 2012 - 2022 (USD Million)
Table 7 Europe CSF management market, by product, 2012 - 2022 (USD Million)
Table 8 Asia Pacific CSF management market, by product, 2012 - 2022 (USD Million)
Table 10 RoW CSF management market, by product, 2012 - 2022 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 CSF management market segmentation
Figure 8 Global CSF management market, 2012 - 2022 (USD Million)
Figure 9 CSF management market dynamics
Figure 10 Key opportunities prioritized, 2014
Figure 11 CSF management market Porter’s analysis
Figure 12 CSF management market PESTEL analysis
Figure 13 CSF management revenue share, by product, 2014 & 2022
Figure 14 CSF shunts stimulation devices market , 2012 - 2022 (USD Million)
Figure 15 CSF drainage stimulation devices market , 2012 - 2022 (USD Million)
Figure 16 CSF Management market share, by region, 2014 & 2022
Figure 17 North America CSF management market , 2012 - 2022 (USD Million)
Figure 18 Europe CSF management market , 2012 - 2022 (USD Million)
Figure 19 Asia Pacific CSF management market , 2012 - 2022 (USD Million)
Figure 20 RoW CSF management market , 2012 - 2022 (USD Million)
Figure 21 Strategy framework
Figure 22 Participant categorization
- B. Braun Melsungen AG
- Johnson & Johnson Services, Inc
- Integra LifeSciences Corporation
- Spiegelberg GmbH & Co. KG
- Medtronic, Inc.
- BECKERSMITH MEDICAL, Inc
- Phoenix Biomedical Corp.
- Möller Medical GmbH
- Elekta AB